Antibody Pharmacokinetics and Pharmacodynamics

This publication has 101 references indexed in Scilit:

• Pharmacokinetic/Pharmacodynamic Modeling of the Effects of Intravenous Immunoglobulin on the Disposition of Antiplatelet Antibodies in a Rat Model of Immune Thrombocytopenia
  Journal of Pharmaceutical Sciences, 2003
• Basiliximab
  Drugs, 2003
• The role of intravenous immunoglobulin therapy in autoimmune and inflammatory disorders
  Neurological Sciences, 2002
• Pharmacokinetics of Gemtuzumab Ozogamicin, an Antibody‐Targeted Chemotherapy Agent for the Treatment of Patients with Acute Myeloid Leukemia in First Relapse
  The Journal of Clinical Pharmacology, 2001
• Interspecies Scaling of Clearance and Volume of Distribution for Digoxin-Specific Fab
  Toxicology and Applied Pharmacology, 1996
• Pharmacokinetic Aspects of Digoxin-Specific Fab Therapy in the Management of Digitalis Toxicity
  Clinical Pharmacokinetics, 1995
• Comparison of four basic models of indirect pharmacodynamic responses
  Journal of Pharmacokinetics and Biopharmaceutics, 1993
• Fab-bound Colchicine Appears to Adopt Fab Fragment Disposition in Rats
  Journal of Pharmacy and Pharmacology, 1992
• Ablation of human choriocarcinoma xenografts in nude mice by antibody-directed enzyme prodrug therapy (ADEPT) with three novel compounds
  European Journal of Cancer and Clinical Oncology, 1991
• Past, present, and future immunotherapy of snake venom poisoning
  Annals of Emergency Medicine, 1987